Physician

Peter A Nixon, MD

According to 2025 Medicare claims, Peter Nixon, MD (NPI: 1467438531) practices ophthalmology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is AUSTIN RETINA ASSOCIATES PLLC (NPI: 1114999828; TIN: 74-2034080) and primary practice location at 78705-1169.

Nixon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,516 traditional Medicare patients, billed 33,539 HCPCS/CPT codes, and received $5,566,681 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 383 prescription claims across 171 beneficiaries totaling $18,664 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 13 records totaling $739. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,458,013 to $5,566,681. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $31,207 and ending at $18,664. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,344	20,211	$1,458,013
2016	1,486	21,512	$2,576,609
2017	1,633	19,443	$2,644,789
2018	1,776	17,537	$2,441,678
2019	1,753	16,894	$3,554,689
2020	1,545	16,140	$4,225,826
2021	1,594	17,488	$4,723,197
2022	1,739	18,412	$5,038,438
2023	1,591	22,673	$5,175,649
2024	1,516	33,539	$5,566,681

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	139	336	$31,207
2016	161	400	$37,804
2017	163	438	$38,260
2018	190	387	$25,154
2019	193	459	$33,932
2020	159	378	$30,037
2021	222	455	$30,209
2022	244	543	$28,966
2023	159	337	$34,676
2024	171	383	$18,664

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	592	695	$133
67028	Injection of drug into eye	623	2,764	$103
92014	Established patient complete exam of visual system	608	647	$92
92134	Imaging of retina	1,251	3,538	$31
92250	Photography of the retina	414	550	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	31	914	$5,592
Prednisolone Acetate	Prednisolone Acetate	105	3,680	$3,186
Ketorolac Tromethamine	Ketorolac Tromethamine	83	2,631	$1,350
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	80	1,717	$781
Timolol Maleate	Timolol Maleate	32	1,633	$213

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$739	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter A. Nixon, MD?

Tedicare shows public-source Medicare data for Peter A. Nixon, MD (NPI 1467438531), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter A. Nixon, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter A. Nixon, MD?

Peter A. Nixon, MD is linked to AUSTIN RETINA ASSOCIATES PLLC (billing NPI 1114999828) in the available physician profile data.

Does Peter A. Nixon, MD have Open Payments data?

Peter A. Nixon, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.